Extracellular Vesicles in Advanced Prostate Cancer: Tools to Predict and Thwart Therapeutic Resistance
Prostate cancer (PCa) is the second most frequent cancer and the fifth leading cause of cancer death among men worldwide. At first, advanced PCa is treated by androgen deprivation therapy with a good initial response. Nevertheless, recurrences occur, leading to Castrate-Resistance Prostate Cancer (C...
Main Authors: | Carolina Saldana, Amene Majidipur, Emma Beaumont, Eric Huet, Alexandre de la Taille, Francis Vacherot, Virginie Firlej, Damien Destouches |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3791 |
Similar Items
-
Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management
by: Virginie Vlaeminck-Guillem, et al.
Published: (2018-06-01) -
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines
by: Joshua S. Brzozowski, et al.
Published: (2018-09-01) -
The Role of Extracellular Vesicles in Cancer: Cargo, Function, and Therapeutic Implications
by: James Jabalee, et al.
Published: (2018-08-01) -
Extracellular vesicles therapy: opportunities, mechanisms and perspectives
by: F. S. Velikonivtsev, et al.
Published: (2020-11-01) -
Extracellular Vesicles in Neuroinflammation
by: Giulia Marostica, et al.
Published: (2021-01-01)